Petros Grivas: Trial is open and we look for more sites!
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and director of the University of Washington School of Medicine’s Genitourinary Cancers Program, shared a post by ECOG-ACRIN Cancer Research Group on X, adding
“Trial is open and we look for more sites! Appreciate support to help patients with Upper Tract Urothelial Cancer (UTUC)!”
Quoting ECOG-ACRIN Cancer Research Group’s post:
“EA8192, led by Jean Hoffman-Censits and Petros Grivas, is a phase II/III clinical trial of durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy.”
Read further.
Source: Petros Grivas/X and ECOG-ACRIN Cancer Research Group/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”